Financial Astrology Terminal

Healthcare ETFs Explained 2027: How Healthcare Sector Funds Work

An educational overview of healthcare exchange-traded funds.

Healthcare ETFETF basicsExplainer
Healthcare ETFs (Healthcare ETF) analysis illustration

What Is a Healthcare ETF?

A healthcare ETF is an exchange-traded fund that holds stocks of companies in the healthcare sector, such as pharmaceutical makers, biotechnology firms, medical device companies, health insurers and healthcare service providers. It offers exposure to the sector through a single fund.

Sector ETFs became widely available in the late 1990s, including funds tracking the healthcare sector of the S&P 500.

Healthcare is one of the largest sectors of the U.S. stock market.

How Healthcare ETFs Work

Broad healthcare ETFs hold large companies across the whole sector, while narrower funds focus on areas such as biotechnology, medical devices or genomics.

Healthcare is often considered defensive because demand for medical care is relatively stable, though biotech funds can be highly volatile.

Fund results depend on the index used, how holdings are weighted and the fund's costs.

Types of Healthcare ETFs

Broad healthcare funds include sector funds tracking large-cap healthcare indexes. Narrower funds focus on biotech, medical devices or healthcare providers.

Equal-weight healthcare funds give smaller companies more influence than market-cap-weighted funds.

How to Compare Healthcare ETFs

These measures help compare healthcare funds:

  • Expense ratio
  • Sub-sector weights (pharma, biotech, devices, insurers)
  • Concentration in the largest holdings
  • Index methodology
  • Trading liquidity

Risks of Healthcare ETFs

Healthcare ETFs carry sector-specific risks:

  • Drug pricing and healthcare regulation
  • Clinical trial and patent risks in individual holdings
  • Concentration in a few large companies
  • Higher volatility in biotech-focused funds

From Medical Spending To Company Revenue

A patient's medical bill does not flow directly to every company represented in a healthcare fund. The path depends on the product or service and on who pays for it. A hospital records revenue for care delivered, while an insurer collects premiums and pays covered claims. A drug manufacturer sells medicines through a distribution chain that can include wholesalers, pharmacies and other intermediaries. Following these links helps explain why a change in the volume of care can affect different holdings in different ways. The distinction between the user of a product, the party choosing it and the party paying for it is particularly important in healthcare.

Insurers negotiate coverage and payment arrangements with providers, while employers, governments and individuals may finance insurance premiums. The amount billed for a service can differ from the amount a provider ultimately expects to collect. Provider revenue therefore reflects both activity and payment terms, including adjustments for contractual arrangements and amounts that may not be collected. When reading a provider's results, changes in patient volumes should be considered alongside changes in the types of services delivered and the mix of payers. A shift toward more complex procedures, for example, can change revenue per patient even if the number of patients is unchanged.

Drug manufacturers face a different set of accounting and commercial relationships. Reported sales generally reflect deductions such as rebates and returns rather than simply the list prices of medicines multiplied by units sold. A company's disclosures can explain how these deductions are estimated and how changes in product mix affect revenue. Distribution businesses may report substantial revenue because they handle expensive products, even though the portion retained after paying suppliers can be comparatively small. Revenue size alone therefore says little about profitability across healthcare industries. Comparing gross profit and operating profit can help separate the value retained on sales from spending on the rest of the business.

Reading Healthcare Company Accounts

The income statement shows revenue, costs and profit for a reporting period, but the most useful operating measures vary by business. For a manufacturer, gross profit can help show what remains after the direct costs of producing goods. For a health insurer, claims costs are central to understanding the relationship between premiums and medical spending. For a hospital operator, labor and facility costs are important components of the cost of delivering care. Comparing these businesses using one margin measure without considering their activities can obscure more than it reveals. Each measure should also be read in the context of the company's own definitions and the activities included in its reported segments.

Research and development spending is an operating expense for many drug and biotechnology companies. It covers work on potential products as well as efforts related to existing treatments, and its timing may differ from the timing of any related sales. Acquisitions can also complicate comparisons: purchased intangible assets may be amortized over time, and impairment charges can arise when recorded asset values are reassessed. Notes to the financial statements help distinguish recurring operating costs from the accounting effects of particular transactions. Companies may present adjusted measures alongside accounting results; the reconciliation shows which items were excluded and allows readers to assess those choices.

The cash flow statement adds another view of operations. Cash collected from customers can arrive in a different period from reported revenue, while inventory purchases and payments to suppliers also affect operating cash flow. Capital spending on facilities and equipment appears separately from operating cash flow. For a fund that owns many businesses, reviewing a few major holdings' cash flows and balance sheets can reveal differences that a sector-wide earnings figure would otherwise conceal. Changes in receivables or inventory deserve attention alongside management's explanation, since they may reflect timing as well as changes in business activity.

Inside The ETF Structure

ETF shares trade on an exchange, while the fund also calculates a net asset value based on its assets and liabilities. An exchange transaction between investors does not necessarily require the fund to buy or sell its holdings. Separately, authorized participants can create or redeem ETF shares in large blocks through transactions with the fund. These processes connect the trading market with the underlying portfolio, although the market price and net asset value can differ during the trading day. Trading conditions and the ease of valuing underlying securities can influence that difference, particularly when the underlying market is moving quickly.

A fund's distributions can come from dividends received on its holdings or from realized gains within the portfolio. The amount distributed is not the same thing as the total economic result of owning fund shares: changes in the value of the shares also matter. Reinvesting a distribution changes the number of shares owned, while taking it in cash leaves that cash outside the fund. The fund's distribution records and annual reports describe the sources and treatment of payments. A distribution can change the fund's net asset value because cash or other assets leave the portfolio when it is paid.

Fund documents also explain whether securities lending is permitted. In such arrangements, the fund lends portfolio securities to a borrower in exchange for collateral and a fee. The arrangement can generate income, but it also introduces borrower and collateral-related risks. The share of lending income retained by the fund and the operating arrangements depend on the fund's policies. Annual reports and related disclosures provide context for understanding how this activity fits into the fund's operations. Collateral arrangements and the identity of the lending agent are useful details when reading these disclosures, as practices differ among funds.

Portfolio Changes And Classification

A healthcare index is a set of rules as well as a list of companies. Index providers decide which businesses qualify, how corporate changes are handled and when the membership or weights are reviewed. A company operating across several fields may be assigned to one sector even if some of its activities resemble another. As a result, two funds described as broad healthcare funds can have different boundaries around what counts as healthcare, even before differences in weighting are considered. The index methodology and constituent list show the actual scope more clearly than a short fund label can convey on its own.

Mergers, spin-offs and other corporate actions can change a portfolio without a fund manager making a conventional stock-picking decision. An index may add a newly separated company, remove an acquired company or adjust a position after a restructuring, according to its published rules. Index reviews can also change eligibility as companies' characteristics change. A fund's holdings report is a snapshot; comparing reports from different periods can show how corporate events and scheduled reviews affected the portfolio. Such changes can also generate trading inside the fund, though the relationship between portfolio turnover and trading costs depends on the transactions involved.

Geography is another distinction that may be less obvious from a fund's name. A portfolio limited to companies listed in one market can still have indirect exposure to customers, suppliers and currencies elsewhere because large healthcare businesses often operate internationally. Conversely, a global portfolio may own companies listed in several markets. Company location, place of listing and location of sales describe different things, so each can answer a different question about the economic activity represented in a fund. A company's annual report may break revenue down by region, offering a different perspective from the country labels in a portfolio summary.

Conclusion: Understanding Healthcare ETFs

Healthcare ETFs provide diversified exposure to a large and varied sector. Understanding whether a fund is broad or focused, how it weights holdings and what it costs explains much of the difference between funds.

Frequently asked questions

What does a healthcare ETF hold?

Stocks of pharmaceutical, biotech, medical device, insurance and healthcare service companies.

Are healthcare ETFs defensive?

Broad healthcare funds are often considered defensive, but biotech funds can be volatile.

What should I compare between healthcare ETFs?

Expense ratio, index methodology, sub-sector weights and concentration.